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The reported hazard ratios for two of the 46 papers
included in this systematic review were incorrect. The esti-
mates from Currie et al (2009) (reference 3) and Currie et
al (2013) (reference 47) should have been inverted. This
error affected some of the results reported in the abstract
and the main text; the relevant data points on Figures 2, 3
and 4 and in the supplementary table; some of the data in
Table 4; and one sentence in the discussion. All these items
have now been corrected. The key results and conclusions
were unaffected by this error.
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